Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Michael Johnson currently holds 192,818 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Michael Johnson has been a net buyer of ZNTL stock. They have purchased $2.7M and sold $2.1M worth of shares.
David Michael Johnson's most recent insider trade was on Jun 21, 2024, when they sold 48,429 shares at $0.00 per share.
David Michael Johnson serves as Executive at Zentalis Pharmaceuticals, Inc. (ZNTL). They have executed 41 insider transactions totaling $4.8M over their tenure at the company.
David Michael Johnson holds the position of Executive at Zentalis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
David Michael Johnson has shown a buying trading pattern, with $2.7M in total purchases and $2.1M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by David Michael Johnson was on Apr 5, 2021, when they sold $561.0K worth of ZNTL shares. This transaction involved 12,897 shares at $43.50 per share.
David Michael Johnson currently owns 192,818 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Michael Johnson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Michael Johnson has 41 Form 4 filings on record as an insider at Zentalis Pharmaceuticals, Inc..
Set alerts for David Michael Johnson and 40,000+ other insiders.